| 2014 | Activation of YAP1 Is Associated with Poor Prognosis and Response to Taxanes in Ovarian Cancer | 정우진 | Article |
| 2024 | Butyrate as a Potential Modulator in Gynecological Disease Progression | 양창원 | Review |
| 2024 | Case report: Extraskeletal Ewing sarcoma with a germline pathogenic variant of <i>SMARCA4</i> | 김윤환 | Article |
| 2015 | Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment | 권영주 | Article |
| 2019 | Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression | 김현정 | Article |
| 2022 | Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R | 권영주; 이윤실; 황수연 | Article |
| 2023 | Impact of 18F-FDG PET on the Management in Patients With Recurrent Gynecologic cancer: A Meta-analysis | 윤혜전 | Article |
| 2024 | Optimizing Outcomes: Bevacizumab with Carboplatin and Paclitaxel in 5110 Ovarian Cancer Patients—A Systematic Review and Meta-Analysis | 이화정; 이정연; 김유진 | Review |
| 2019 | Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation | 박윤정 | Article |
| 2017 | Regulation of HGF and c-MET interaction in normal ovary and ovarian cancer: Importance of targeting c-MET and HGF interaction | 권영주 | Review |
| 2016 | Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer | 주웅; 안정혁; 성혜윤 | Article |
| 2017 | Thiol-reducing agents prevent sulforaphane-induced growth inhibition in ovarian cancer cells | 김승철; 권영주 | Article |
